Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: December 19, 2017
Event: Entry into a Material Definitive Agreement regarding the extension of a joint venture.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is a legal disclosure regarding a contractual agreement.
Material Changes and Agreement Details
On December 19, 2017, The Clorox Company and The Procter & Gamble Company (collectively, the "Parties") executed the First Extension and Amendment to their Amended and Restated Joint Venture Agreement (JV Agreement). Key terms include:
- Effective Date: December 20, 2017.
- New Expiration: The JV Agreement term is extended to January 31, 2026.
- Previous Expiration: Without this extension, the agreement would have expired on January 31, 2023.
- Future Extension Option: Either party may request an additional seven-year extension (terminating January 31, 2033) by providing written notice prior to January 31, 2025.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, or specific risk factors beyond the standard termination provisions of the joint venture agreement. The primary contingency is the potential termination of the agreement on January 31, 2026, if no further extension is agreed upon by January 31, 2025.
Investor Verification Checklist
- Verify the operational impact of the joint venture extension on Clorox's product portfolio and supply chain.
- Confirm the specific financial terms and profit-sharing arrangements within the amended JV Agreement.
- Monitor the timeline for the potential second extension request (deadline: January 31, 2025).
- Review subsequent filings for any changes to the joint venture structure or termination notices.